Aegis Patient Portal Launches Combined Tests for Influenza A/B a

Aegis Patient Portal Launches Combined Tests for Influenza A/B and SARS-CoV-2

Common Questions People And Society

Aegis patient portal is a powerful solution for health care providers and their patients. It leverages best practices and innovative technology to deliver insightful information to sports organizations, employers, and healthcare providers. While shipping delays can cause a delay in receiving the final report, the portal gives patients the information they need to stay informed about their health. For instance, a patient can search for a study or look for specific products. By following the instructions on the portal, patients can track their order’s progress and access the latest updates.

Test for SARS-CoV-2

Aegis Sciences Corporation has announced the launch of a new combined test for SARS-CoV-2 and Influenza A/B viruses. This test will enable the identification of the specific strain and detect novel mutations within the virus. Positive samples will be analyzed by next-generation sequencing. Results will be reported to the CDC along with geographic source information. The company also provides diagnostic services to government agencies and pharmaceutical companies.

Aegis has several labs around the world, including the U.S., and is now trying to reach patients remotely with its Patient Portal. Founded in 1990, the company has been a leader in the medical field for 23 years. Aegis Science Corporation has pledged to provide assistance to healthcare providers and has generated more than 11 million Covid tests to date. It is one of the leading laboratories worldwide, providing high-quality tests to confirm or rule out the disease.

Aegis’ biopharma lab was the go-to lab for the COVID-19 response task forces. The small lab-processed approximately 3,500 COVID-19 tests per day, with a 24-hour turnaround time. As the number of cases of COVID-19 increased, the demand for testing increased. In response, Aegis secured an NIH grant of $6.6 million to build out its biopharma lab. With the new lab, Aegis is targeting 60,000 tests per day.

Test for influenza A/B virus

Aegis Laboratories is a medical laboratory with multiple locations in the United States and worldwide. Their goal is to reach patients virtually and better understand their needs. Aegis strives to provide exceptional quality care and a patient-centered healthcare experience. They recently launched a merged test for influenza A/B virus and SARS-CoV-2 virus. These tests are fast, accurate, and available for patients to request by phone, email, or online.

Aegis has been a leader in clinically advanced respiratory viral testing and consulting services. Their combination COVID-19/FLU A/B virus test is available for individuals with respiratory viral infection consistent with COVID-19. Patients can easily request the test online by entering their name and phone number to get a real-time result. This test has a high success rate, indicating that it is accurate and reliable.

Aegis has launched COVID-19 testing services in April 2020. It has since rapidly expanded its testing capacity. It was recently selected to participate in the National Institutes of Health’s RADx program and received an additional NIH grant to expand COVID-19 testing capacity to 60,000 tests per day by September 2020. Aegis continues to maintain its industry-leading turnaround times. They currently perform more than 110,000 tests a day and can complete them in less than 24 hours.

Test for Covid-19

Aegis Sciences Corporation, a leader in clinically innovative medication compliance testing, is now providing public health reporting for COVID-19 diagnostic tests in all 50 states. The company was selected to participate in the National Institutes of Health’s (NIH) Rapid Acceleration of Diagnostics (RADX) program, which will allow it to increase its testing capacity to 60,000 tests per day by September 2020. To meet the growing demand for COVID-19 testing, Aegis acquired an NIH grant to expand its biopharma lab to 60,000 tests per day.

Aegis has 23 years of experience in running a patient portal. Registered patients can sign in to the patient portal to view test results and check their standing. Once you have logged in, you can review and print your COVID-19 test results. Click on the ‘Individual Portal’ link to access the patient portal. Aegis’s patient portal allows you to view test results and track your progress.

Aegis also collaborated with Walgreens to expand COVID testing across the country. As a result, Aegis lab now employs 550 employees and provides testing for COVID-19 in more than 5,000 Walgreens stores nationwide. Aegis also has a contract with the Centers for Disease Control for the identification of strains. By using high-throughput next-generation sequencing techniques, Aegis now provides 15% of the nation’s CoVID testing.